genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Big Data
A Unicorn Rivalry Shaping the Future of the Synbio Industry
Gene Therapy
At Orchard, Moving from Pruning to Planting
GEN Edge
Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
AAV (Adeno-associated virus)
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
Coronavirus
Rough Surf Ahead for California
News
Epigenetics
DNA Methylation Sites IDed by Machine Learning Algorithm
Autism
Autism-Related Social Behaviors in Mice Tied to Gene Mutation, and Normalized…
News
Enzyme Identified that May Provide Novel Therapeutic Approach to Huntington’s
Cancer
Epigenetic Regulation Key to Daily Formation of Billions of Blood Cells
Antibodies
Gut Microbiome Influences B Cell and Antibody Repertoire
Insights
All
Trends for 2020
Bioprocessing
Remote Control of CAR T Cells to Enhance Safety
Bioprocessing
Standardizing Cell and Gene Therapy Remains Bioindustry Goal
Bioprocessing
COVID-19 Increases Demand for Next-Generation Bioprocessing Technology
Bioprocessing
Moving Quickly but Smartly from R&D to Commercialization
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Epigenetics
DNA Methylation Sites IDed by Machine Learning Algorithm
Autism
Autism-Related Social Behaviors in Mice Tied to Gene Mutation, and Normalized…
Cancer
Epigenetic Regulation Key to Daily Formation of Billions of Blood Cells
Antibodies
Gut Microbiome Influences B Cell and Antibody Repertoire
Magazine
July 2020 Vol. 40 No. 7
Rosalind Franklin the Scientist
July 2020 Vol. 40 No. 7
COVID-19 Research: Women Are Changing the Face of the Pandemic
July 2020 Vol. 40 No. 7
CRISPR Screening Explores New Dimensions
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Commentary
Clues to Healthier Aging in Cellular Senescence
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Tutorial
In-Depth GPCR Signaling Characterization for Improved Drug Discovery
New Products
Precoated Plates
New Products
Liquid Chromatograph Mass Spectrometer
New Products
RNA Quantification Assay
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Biogen
Biogen
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Biogen
Biogen, AbbVie Withdraw MS Drug Zinbryta after Brain Disorders Spark EMA Review
Biogen
Biogen Replenishes Eye Disease Gene Therapy Pipeline with Planned $877M Nightstar Acquisition
Biogen
Biogen Halts Development of Tysabri for Acute Ischemic Stroke after Phase IIb Failure
Biogen
“Some Hope”: Biogen, Eisai Release Positive Phase II Results for Alzheimer’s Candidate
Biogen
AbbVie Launches, Biogen Tweaks Alzheimer’s Collaborations
Biogen
Biogen Buys Option to TMS’ Phase II Stroke Candidate
Biogen
Biogen, Vir to Partner on Manufacturing Antibodies to Treat COVID-19
Biogen
Biogen to Develop Alkermes’ MS Candidate ALKS 8700
Biogen
Biogen, AbbVie Withdraw MS Drug Zinbryta after Brain Disorders Spark EMA...
Biogen
Biogen Halts Development of Tysabri for Acute Ischemic Stroke after Phase...
Biogen
Biogen Replenishes Eye Disease Gene Therapy Pipeline with Planned $877M Nightstar...
Biogen
AbbVie Launches, Biogen Tweaks Alzheimer’s Collaborations
Biogen
BMS Licenses mAb and Fusion Protein Drugs to Biogen and to...
Biogen
Biogen Shares Surge after Reversal on Alzheimer’s Candidate Aducanumab
Biogen
Fujifilm Diosynth to Expand with $890M Purchase of Biogen’s Danish Biologics...
1
2
Page 1 of 2
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
